Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-8 of 8 for optic nerve

Edit search filters
  1. Low-Dose or High-Dose Lenalidomide in Treating Children with Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma

    Rochester, MN

  2. A Study to Compare Surgical Idiopathic Intracranial Hypertension Treatment

    Rochester, MN

  3. Evaluating Optic Nerve Disease with OCT Angiography

    Rochester, MN

  4. A Study to Evaluate a Color Test for Patients with Optic Nerve Diseases

    Rochester, MN

  5. Using Critical Flicker Fusion to Distinguish Causes of Vision Loss

    Rochester, MN

  6. Developing Criteria for Treatment of Neurofibromatosis Type 1 Associated Optic Pathway Glioma

    Rochester, MN

  7. A Study to Assess for Changes in Optic Nerve Structure and Function due to Changes in Cerebrospinal Fluid Pressure

    Rochester, MN

  8. A Study to Evaluate the Effectiveness of Critical Flicker Fusion in Distinguishing Different Causes of Altered Vision

    Rochester, MN

.

Mayo Clinic Footer